UK government proposals on the country’s statutory scheme for branded medicine pricing that include a “lifecycle adjustment” mechanism to allow lower a rebate rate for medicines in competitive markets have been welcomed by the British Generic Manufacturers Association.
BGMA Welcomes ‘Differentiated’ Approach To UK Statutory Scheme
Off-Patent Industry Association Praises Government’s ‘Lifecycle Adjustment’ Rebate Proposal
Proposals published by the UK government as part of a consultation on its statutory scheme for branded medicine pricing have been welcomed by local off-patent industry association the BGMA. The proposals include a “lifecycle adjustment” mechanism to allow a lower rebate rate for medicines being sold in competitive markets.
